Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Cancers|January 10, 2026
Patient-Reported Financial Burden in Head and Neck Cancer Undergoing RadiotherapyRenata Zahu, Monica Emilia Chirila, Otilia Ciobanu, et al.Urologia Internationalis|May 8, 2014
Management of bone metastases in patients with castration-resistant prostate cancerRichard Cathomas, Zoltan Bajory, Mounira Bouzid, et al.Chirurgia (Bucharest, Romania : 1990)|March 5, 2019
Mind the Gap Between Scientific Literature Recommendations and Effective Implementation. Is There Still a Role for Surgery in the Treatment of Locally Advanced Cervical Carcinoma?Alexandru Blidaru, Cristian Bordea, Traean Burcoş, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|June 22, 2012
Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cellsCiprian Tomuleasa, Olga Soritau, Anamaria Orza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2017
Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m2) and the Currently Approved Dose (25 mg/m2) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICAMario Eisenberger, Anne-Claire Hardy-Bessard, Choung Soo Kim, et al.Photodiagnosis and Photodynamic Therapy|January 12, 2020
The in vivo modulatory effects of Cornus mas extract on photodynamic therapy in experimental tumorsIstván-Péter Laszló, Mihaela Ramona Laszló, Vlad Toma, et al.Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|February 8, 2026
Anatomy-based definition of posterior neck in head and neck VMAT plan optimization as potential new organ at riskRenata Zahu, Alexandru Farcasanu, Andreea Eva, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 27, 2014
Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cellsMihaela D Aldea, Bobe Petrushev, Olga Soritau, et al.Lancet (London, England)|November 23, 2024
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial designAlberto Bossi, Stéphanie Foulon, Xavier Maldonado, et al.European Journal of Cancer (Oxford, England : 1990)|October 4, 2025
Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trialAdrien Rousseau, Maryam Karimi, Stefan Michiels, et al.Pageof 5